Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Jul;74(2):291–296. doi: 10.1038/bjc.1996.355

Fertility, reproductive outcomes, and health of offspring, of patients treated for Hodgkin's disease: an investigation including chromosome examinations.

A J Swerdlow 1, P A Jacobs 1, A Marks 1, E J Maher 1, T Young 1, J C Barber 1, G Vaughan Hudson 1
PMCID: PMC2074565  PMID: 8688339

Abstract

Reproductive outcomes and health of offspring were investigated in 340 patients with Hodgkin's disease first treated at Mount Vernon Hospital, Middlesex, England, at ages under 40 (females) or 45 (males) during 1970-91. Information on offspring was obtained from case-notes and postal questionnaires to the patients. Eleven men and 16 women who had conceived any children after treatment were then interviewed. There was no excess of stillbirths, low birthweight or cogenital malformations, and no cancers have occurred in the 49 offspring after treatment. There was a significant excess of twins, compared with national expectations, in offspring of female patients (RR = 8.52, P = 0.025). Aggregation of series from the literature also showed an excess of twins. Chromosomes from cultures of peripheral lymphocytes from 45 children born to 25 patients (11 men and 14 women) after treatment were examined for numerical abnormalities and for structural abnormalities at the 550 or greater band level of resolution. All were normal except in one child with Down's syndrome (47, XY, +21), for whom we found the origin of the trisomy was from the parent without Hodgkin's disease. The chromosome constitution was also abnormal in one miscarriage (69, XXY; originating from the parent without Hodgkin's disease) and one termination (45, X; for with the parental origin could not be determined) after treatment. The study adds to previous questionnaire data and for the first time provides data also from chromosome analysis, that offspring of patients treated in adulthood for Hodgkin's disease are not at greatly raised risk of genotoxic or other adverse outcomes as a consequence of their parent's treatment. The numbers of offspring assessed in the literature remains small, however, and surveillance of larger numbers of subjects is needed to enable reliable treatment-specific analyses.

Full text

PDF
291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisner J., Wiernik P. H., Pearl P. Pregnancy outcome in patients treated for Hodgkin's disease. J Clin Oncol. 1993 Mar;11(3):507–512. doi: 10.1200/JCO.1993.11.3.507. [DOI] [PubMed] [Google Scholar]
  2. Andrieu J. M., Ochoa-Molina M. E. Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease. Cancer. 1983 Aug 1;52(3):435–438. doi: 10.1002/1097-0142(19830801)52:3<435::aid-cncr2820520308>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  3. Baker J. W., Morgan R. L., Peckham M. J., Smithers D. W. Preservation of ovarian function in patients requiring radiotherapy for para-aortic and pelvic Hodgkin's disease. Lancet. 1972 Jun 17;1(7764):1307–1308. doi: 10.1016/s0140-6736(72)91035-5. [DOI] [PubMed] [Google Scholar]
  4. Blatt J., Mulvihill J. J., Ziegler J. L., Young R. C., Poplack D. G. Pregnancy outcome following cancer chemotherapy. Am J Med. 1980 Dec;69(6):828–832. doi: 10.1016/s0002-9343(80)80007-6. [DOI] [PubMed] [Google Scholar]
  5. Dodds L., Marrett L. D., Tomkins D. J., Green B., Sherman G. Case-control study of congenital anomalies in children of cancer patients. BMJ. 1993 Jul 17;307(6897):164–168. doi: 10.1136/bmj.307.6897.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Doll R., Evans H. J., Darby S. C. Paternal exposure not to blame. Nature. 1994 Feb 24;367(6465):678–680. doi: 10.1038/367678a0. [DOI] [PubMed] [Google Scholar]
  7. Draper G. J. General overview of studies of multigeneration carcinogenesis in man, particularly in relation to exposure to chemicals. IARC Sci Publ. 1989;(96):275–288. [PubMed] [Google Scholar]
  8. Gabriel D. A., Bernard S. A., Lambert J., Croom R. D., 3rd Oophoropexy and the management of Hodgkin's disease. A reevaluation of the risks and benefits. Arch Surg. 1986 Sep;121(9):1083–1085. doi: 10.1001/archsurg.1986.01400090115021. [DOI] [PubMed] [Google Scholar]
  9. Green D. M., Hall B. Pregnancy outcome following treatment during childhood or adolescence for Hodgkin's disease. Pediatr Hematol Oncol. 1988;5(4):269–277. doi: 10.3109/08880018809037366. [DOI] [PubMed] [Google Scholar]
  10. Green D. M., Zevon M. A., Lowrie G., Seigelstein N., Hall B. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. N Engl J Med. 1991 Jul 18;325(3):141–146. doi: 10.1056/NEJM199107183250301. [DOI] [PubMed] [Google Scholar]
  11. Hawkins M. M., Draper G. J., Smith R. A. Cancer among 1,348 offspring of survivors of childhood cancer. Int J Cancer. 1989 Jun 15;43(6):975–978. doi: 10.1002/ijc.2910430604. [DOI] [PubMed] [Google Scholar]
  12. Hawkins M. M. Is there evidence of a therapy-related increase in germ cell mutation among childhood cancer survivors? J Natl Cancer Inst. 1991 Nov 20;83(22):1643–1650. doi: 10.1093/jnci/83.22.1643. [DOI] [PubMed] [Google Scholar]
  13. Hawkins M. M., Smith R. A. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer. 1989 Mar 15;43(3):399–402. doi: 10.1002/ijc.2910430309. [DOI] [PubMed] [Google Scholar]
  14. Holmes G. E., Holmes F. F. Pregnancy outcome of patients treated for Hodgkin's disease: a controlled study. Cancer. 1978 Apr;41(4):1317–1322. doi: 10.1002/1097-0142(197804)41:4<1317::aid-cncr2820410416>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  15. Horning S. J., Hoppe R. T., Kaplan H. S., Rosenberg S. A. Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med. 1981 Jun 4;304(23):1377–1382. doi: 10.1056/NEJM198106043042301. [DOI] [PubMed] [Google Scholar]
  16. Jacobs P. A., Browne C., Gregson N., Joyce C., White H. Estimates of the frequency of chromosome abnormalities detectable in unselected newborns using moderate levels of banding. J Med Genet. 1992 Feb;29(2):103–108. doi: 10.1136/jmg.29.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Janov A. J., Anderson J., Cella D. F., Zuckerman E., Kornblith A. B., Holland J. C., Kantor A. F., Li F. P., Henderson E., Weiss R. B. Pregnancy outcome in survivors of advanced Hodgkin disease. Cancer. 1992 Aug 1;70(3):688–692. doi: 10.1002/1097-0142(19920801)70:3<688::aid-cncr2820700325>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  18. Kinsella T. J., Trivette G., Rowland J., Sorace R., Miller R., Fraass B., Steinberg S. M., Glatstein E., Sherins R. J. Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin's disease. J Clin Oncol. 1989 Jun;7(6):718–724. doi: 10.1200/JCO.1989.7.6.718. [DOI] [PubMed] [Google Scholar]
  19. Kreuser E. D., Xiros N., Hetzel W. D., Heimpel H. Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease. J Cancer Res Clin Oncol. 1987;113(3):260–266. doi: 10.1007/BF00396383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lacher M. J., Toner K. Pregnancies and menstrual function before and after combined radiation (RT) and chemotherapy (TVPP) for Hodgkin's disease. Cancer Invest. 1986;4(2):93–100. doi: 10.3109/07357908609038252. [DOI] [PubMed] [Google Scholar]
  21. Le Floch O., Donaldson S. S., Kaplan H. S. Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin's disease. Cancer. 1976 Dec;38(6):2263–2268. doi: 10.1002/1097-0142(197612)38:6<2263::aid-cncr2820380612>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  22. Li F. P., Fine W., Jaffe N., Holmes G. E., Holmes F. F. Offspring of patients treated for cancer in childhood. J Natl Cancer Inst. 1979 May;62(5):1193–1197. [PubMed] [Google Scholar]
  23. Li F. P., Gimbrere K., Gelber R. D., Sallan S. E., Flamant F., Green D. M., Heyn R. M., Meadows A. T. Outcome of pregnancy in survivors of Wilms' tumor. JAMA. 1987 Jan 9;257(2):216–219. [PubMed] [Google Scholar]
  24. McKeen E. A., Mulvihill J. J., Rosner F., Zarrabi M. H. Pregnancy outcome in Hodgkin's disease. Lancet. 1979 Sep 15;2(8142):590–590. doi: 10.1016/s0140-6736(79)91650-7. [DOI] [PubMed] [Google Scholar]
  25. Mulvihill J. J., McKeen E. A., Rosner F., Zarrabi M. H. Pregnancy outcome in cancer patients. Experience in a large cooperative group. Cancer. 1987 Sep 1;60(5):1143–1150. doi: 10.1002/1097-0142(19870901)60:5<1143::aid-cncr2820600537>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  26. Neel J. V., Schull W. J., Awa A. A., Satoh C., Kato H., Otake M., Yoshimoto Y. The children of parents exposed to atomic bombs: estimates of the genetic doubling dose of radiation for humans. Am J Hum Genet. 1990 Jun;46(6):1053–1072. [PMC free article] [PubMed] [Google Scholar]
  27. Nomura T. Parental exposure to x rays and chemicals induces heritable tumours and anomalies in mice. Nature. 1982 Apr 8;296(5857):575–577. doi: 10.1038/296575a0. [DOI] [PubMed] [Google Scholar]
  28. Nomura T. X-ray- and chemically induced germ-line mutation causing phenotypical anomalies in mice. Mutat Res. 1988 Apr;198(2):309–320. doi: 10.1016/0027-5107(88)90008-5. [DOI] [PubMed] [Google Scholar]
  29. Ortin T. T., Shostak C. A., Donaldson S. S. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. Int J Radiat Oncol Biol Phys. 1990 Oct;19(4):873–880. doi: 10.1016/0360-3016(90)90007-7. [DOI] [PubMed] [Google Scholar]
  30. Otake M., Schull W. J., Neel J. V. Congenital malformations, stillbirths, and early mortality among the children of atomic bomb survivors: a reanalysis. Radiat Res. 1990 Apr;122(1):1–11. [PubMed] [Google Scholar]
  31. Schilsky R. L., Sherins R. J., Hubbard S. M., Wesley M. N., Young R. C., DeVita V. T. Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. Am J Med. 1981 Oct;71(4):552–556. doi: 10.1016/0002-9343(81)90205-9. [DOI] [PubMed] [Google Scholar]
  32. Senturia Y. D., Peckham C. S., Peckham M. J. Children fathered by men treated for testicular cancer. Lancet. 1985 Oct 5;2(8458):766–769. doi: 10.1016/s0140-6736(85)90640-3. [DOI] [PubMed] [Google Scholar]
  33. Sherman S. L., Petersen M. B., Freeman S. B., Hersey J., Pettay D., Taft L., Frantzen M., Mikkelsen M., Hassold T. J. Non-disjunction of chromosome 21 in maternal meiosis I: evidence for a maternal age-dependent mechanism involving reduced recombination. Hum Mol Genet. 1994 Sep;3(9):1529–1535. doi: 10.1093/hmg/3.9.1529. [DOI] [PubMed] [Google Scholar]
  34. Specht L., Hansen M. M., Geisler C. Ovarian function in young women in long-term remission after treatment for Hodgkin's disease stage I or II. Scand J Haematol. 1984 Mar;32(3):265–270. doi: 10.1111/j.1600-0609.1984.tb01691.x. [DOI] [PubMed] [Google Scholar]
  35. Trasler J. M., Hales B. F., Robaire B. Paternal cyclophosphamide treatment of rats causes fetal loss and malformations without affecting male fertility. Nature. 1985 Jul 11;316(6024):144–146. doi: 10.1038/316144a0. [DOI] [PubMed] [Google Scholar]
  36. Webber L. M., Garson O. M. Fluorodeoxyuridine synchronization of bone marrow cultures. Cancer Genet Cytogenet. 1983 Feb;8(2):123–132. doi: 10.1016/0165-4608(83)90044-4. [DOI] [PubMed] [Google Scholar]
  37. Whitehead E., Shalet S. M., Blackledge G., Todd I., Crowther D., Beardwell C. G. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer. 1983 Sep 15;52(6):988–993. doi: 10.1002/1097-0142(19830915)52:6<988::aid-cncr2820520610>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  38. Yoshimoto Y., Neel J. V., Schull W. J., Kato H., Soda M., Eto R., Mabuchi K. Malignant tumors during the first 2 decades of life in the offspring of atomic bomb survivors. Am J Hum Genet. 1990 Jun;46(6):1041–1052. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES